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Abstract – The present review summarizes information on the synthetic 
approaches to thiazolo[3,2-a][1,3,5]triazines and polyfused systems bearing this 
heterocyclic core since the first report on this structure in 1887. The methods 
allowing access to the heterocyclic systems comprising isomeric 
thiazolo[3,4-a][1,3,5]triazine scaffold are also included in the review. Data 
concerning potential applications of the thiazolo[1,3,5]triazines, particularly as 
biologically active agents are discussed. 




2. SYNTHESIS OF THIAZOLO[3,2-a][1,3,5]TRIAZINES AND THEIR POLYFUSED 
ANALOGUES 
2.1. Synthesis of thiazolo[3,2-a][1,3,5]triazines by annelation of the 1,3,5-triazine ring onto a thiazole 
scaffold. 
2.1.1. Synthesis of thiazolo[3,2-a][1,3,5]triazines using Mannich condensation. 
2.1.2. Synthesis of thiazolo[3,2-a][1,3,5]triazines using multicomponent reactions of thiazole derivatives 
with heterocumulenes. 
2.1.3.  Synthesis of thiazolo[3,2-a][1,3,5]triazines using other multicomponent reactions of 
2-aminothiazoles and their derivatives. 
2.1.4. Synthesis of thiazolo[3,2-a][1,3,5]triazines via reactions of 2-aminothiazoles with C-N-C triatomic 
synthons.  
 
2.1.5. Synthesis of thiazolo[3,2-a][1,3,5]triazines via formal [4+2] cycloaddition.  
2.1.6. Synthesis of thiazolo[3,2-a][1,3,5]triazines via 1,3,5-triazine ring annelation on 2-substituted 
thiazoles using one-carbon inserting reagents.  
2.1.7. Synthesis of thiazolo[3,2-a][1,3,5]triazines via intramolecular cyclization of 2-substituted thiazoles 
with the formation of 1,3,5-triazine ring. 
2.2. Synthesis of thiazolo[3,2-a][1,3,5]triazines by annelation of the thiazole ring onto a 1,3,5-triazine 
scaffold. 
2.3. Synthesis of thiazolo[3,2-a][1,3,5]triazines via formation of the thiazole and 1,3,5-triazine ring.  
3. HETEROCYCLIC SYSTEMS COMPRISING THIAZOLO[3,4-a][1,3,5]TRIAZINE CORE  
4. CONCLUSION  
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1. INTRODUCTION 
In this review, we summarized existing methods of the synthesis of the compounds comprising 
thiazolo[3,2-a][1,3,5]triazine (A) and thiazolo[3,4-a][1,3,5]triazine (B) nuclei (Figure 1) as well as their 
biological activity and applications. Information on the preparation of related fused heterocyclic system 






























A B C  
Figure 1 
The synthesis of first thiazolo[3,2-a][1,3,5]triazine derivative was described by Rathke in 1887.2,3 He 
reported the reaction of thioammeline (1) with 1,2-dibromoethane that afforded 2 (Scheme 1). However, 
this work was not continued and it took more than 70 years for thiazolo[3,2-a][1,3,5]triazines to come 
back to the scene. Until now, a number of effective synthetic procedure have been developed for the 





















During last decade, significant interest has been developed towards the biological activity investigation of 
compounds with the thiazolo[3,2-a][1,3,5]triazine heterocyclic core. The attempted herein 
systematization of the available synthetic methods for the preparation of these compounds aims to 
facilitate further investigation in this emerging field of research.  
There no data on the synthesis of compounds possessing two-ring system B, thus Section 3 covers the 
preparation of more complex polyfused systems comprising thiazolo[3,4-a][1,3,5]triazine structure (B).  
2. SYNTHESIS OF THIAZOLO[3,2-a][1,3,5]TRIAZINES AND THEIR POLYFUSED 
ANALOGUES 
The general methods of synthesis of thiazolo[3,2-a][1,3,5]triazines can be categorized into: (1) annelation 
of the 1,3,5-triazine ring onto a thiazole scaffold, (2) annelation of the thiazole ring onto a 1,3,5-triazine 
scaffold and (3) formation of both rings in the same reaction.  
 
2.1. Synthesis of thiazolo[3,2-a][1,3,5]triazines by annelation of the 1,3,5-triazine ring onto a 
thiazole scaffold. 
The annelation of the 1,3,5-triazine ring onto a thiazole scaffold is the most explored and developed 
approach for the synthesis of thiazolo[3,2-a][1,3,5]triazines. It is further subdivided in this review on the 
basis of the reaction type and structure of the building blocks.  
 
2.1.1. Synthesis of thiazolo[3,2-a][1,3,5]triazines using Mannich condensation. 
The Mannich reaction of 2-aminothiazolin-4-one (3) and its 5-substituted derivatives with formaldehyde 
and variety of amines was extensively explored. The substitution at position 5 of 2-aminothiazolin-4-one 
(3) and nature of the amine used in the reaction were found to determine structure of the product. Thus, 
reaction of 3 with formaldehyde and methylamine or aromatic amines resulted in the formation of 
Mannich bases 5 (Scheme 2).4,5  
However, when t-buthylamine or benzylamine were used in this reaction, hydroxymethylation at position 
5 of 3 took place together with 1,3,5-triazine ring closure providing 6c and 6e.6 Additionally, spiro-fused 
compound 7 was isolated from the reaction of 3 with formaldehyde and t-buthylamine. The hydrolysis of 
6c and 7 was investigated details by Ramsh et al.7 The aminomethylation of amidine moiety of 4 afforded 
3-alkyl and 3-aralkyl substituted 6 (Scheme 2).8 Compounds of this type, e.g. 6d were among leads for 
the development of agents selectively targeting Fanconi anemia pathway-deficient tumors.9 
The pathway of the reaction of 5-alkyl substituted 2-aminothiazolin-4-ones (8) with formaldehyde and 
amines was found to depend on the amine structure and the substitution at position 5 of 8. In the reaction 
with β-naphthylamine, the products of the aminomethylation (9) were obtained exclusively, while their 
 
hydroxymethylated analogues (10) were formed using t-buthylamine (Scheme 3).4,6,8 The reaction of 





























+ +RNH2 n  CH2O
ii: R = t-Bu, 22% (6c); Bn, 28% (6e)
i: R = Me, 65% (5a); Ph, 89% (5b); 3-ClC6H4, 90% (5c); 3-BrC6H4, 88% (5d);
   3-NO2C6H4, 42% (5e); 3-MeC6H4, 84% (5f); 4-MeC6H4, 89% (5g); 







iii: R = Me, 71% (6a); Et, 40% (6b), t-Bu, 70% (6c); c-Hex, 76% (6d);
    Bn, 46% (6e); CHPh2, 98% (6f)
ii
iii












ii: R1 = Me, R2 = t-Bu, 57% (10a); Ph, 91% (10b);
















+ +R2NH2 n  CH2O
ii
i: R1 = Me, R2 = 2-Naphth, 69% (9a)







Similar reaction of 5-arylidene substituted 2-aminothiazolin-4-ones (11) was used for the preparation of a 
series of corresponding Mannich bases 12 (Scheme 4).4,6,10 One of this type of compounds, CCT196755, 













+ +R2NH2 2  CH2O
R1 = H, F, Cl, Br, NO2, Me, OMe, NMe2, NEt2;












Analogously, 13 reacted with formaldehyde and methylamine to produce 14 (Scheme 5).8 These 















R = Ph, 83% (14a); 4-NO2C6H4, 77% (14b); 4-MeC6H4, 75% (14c); 3-Py, 50% (14d); 4-Py, 46% (14e)





2.1.2. Synthesis of thiazolo[3,2-a][1,3,5]triazines using multicomponent reactions of thiazole 
derivatives with heterocumulenes. 
The pathways of multicomponent reactions of thiazoles with heterocumulenes were found to involve the 
cycloaddition, which may be accompanied by other processes depending on structure of the substrate and 
reaction conditions. The most common heterocumulenes used in the reaction were isocyanates.  
Several cycloaddition reactions of 2-substituted thiazolines with isocyanic acid and its derivatives were 
used for the synthesis of thiazolo[3,2-a][1,3,5]triazin-2,4-diones. Thus, the reaction of thiazolines 15 with 
two molecules of isocyanic acid resulted in the annelation of 2,4-dioxotriazine ring affording 16 (Scheme 






























i: petroleum ether or acetone, rt, 18 h 






i: 100 oC, 5 h 
R1 = N-morpholinyl, R2 = -Naphth, 42% (17c)  
Scheme 7 
2-Aminothiazoline (18) reacted with excess of phenyl isothiocyanate affording 
thiazolo[3,2-a][1,3,5]triazine 20, which was rationalized to form via the triazine ring closure of 
intermediate 1:2 adduct 19 with subsequent elimination of hydrogen sulfide (Scheme 8).14 The structure 
of 20 was unequivocally established using X-ray crystallography.15 An attempt to obtain similar product 






























Another thiazoline derivative, formamidine 21, reacted with aryl isocyanates in mild conditions via the 
[4+2] cycloaddition (vide infra Scheme 58).16 However, heating 21 with excess of aryl isocyanates in 
benzene afforded 1:2 adduct 22 (Scheme 9).16 Using higher temperature and excess of aryl isocyanates 
resulted in the formation of 23. In this case, the synthetic pathway might be rationalized by [4+2] 
cycloaddition of presumable intermediate - thiazolin-2-yl isocyanate (24) and aryl isocyanate molecule.  
It was shown in the same work,16 that formamidine 25 reacted with aryl isocyanates affording the 
formation of 3-arylthiazolo[3,2-a][1,3,5]triazin-2,4-diones (26) in all of the reaction conditions applied 
(Scheme 10).  









R = Ph, 75% (22a); 














R = Ph, 84% (23a); 
4-MeC6H4, 92% (23b)

































i:  2  PhNCO, Et2O, 20 
oC, 16 h
R = Ph, 65% (26a); 
i:  2  4-MeC6H4NCO, benzene, 80 
oC, 1 h















R2 RNCO, 115 oC, 16 h




Instead of expected [4+2] cycloaddition (vide infra Scheme 60), heating 
2-(4-dimethylaminobenzylidenamino)benzothiazole (29a) with phenyl isocyanate or phenyl 
isothiocyanate in inert solvent resulted in the formation of the corresponding 2-benzothiazolyl isocyanate 
 
or 2-benzothiazolyl isothiocyanate (30) (Scheme 12).17 In case of the excess of phenyl isocyanate, the 
cycloaddition afforded 28a. If no excess of phenyl isocyanate was available, 2-benzothiazolyl isocyanate 
as well as its thio-analogue (30) dimerized to 31 (Scheme 12). The electronodonor properties of the 
dimethylamino group were proposed to be responsible for the reaction pathway. However, the basicity of 
this group seems to be a more important factor determining the product structure.  
N
S N
i: PhNCO (2 eq.), toluene, reflux, 16 h - 28a (60%)




























3-Arylthiazolo[3,2-a][1,3,5]triazin-2,4-diones (26 and 28) were also prepared by heating corresponding 






2 RNCO, Py, 135 oC, 3-4 hN
S NHAc
O











2 RNCO, Py, 135 oC, 3-4 hN
S NHAc
O
R = Ph, 75% (28a); 3-ClC6H4, 87% (28c); 4-ClC6H4, 90% (28d); 








2-Aminothiazole 34 was reported19 to react with aryl isocyanates in pyridine affording the formation of 







2 R2NCO, Py, reflux, 4 h
O






Benzofused analogues 37 were synthesized from 2-aminobenzothiazoles (36) (Scheme 16).20 The 
compounds 37 underwent biological screening of against Mycobacterium tuberculosis H37RV. The most 











2 R2NCO, Py, reflux, 6-8 h





Another series of tricyclic thiazolo[3,2-a][1,3,5]triazines (39), which possessed anthelmintic activity 









2 RNCO, Py, reflux, 4-6 h
O





The reactions of 2-thiazolyliminotriphenylphosphorane (40) with various heterocumulenes were studied 
in details by Bödeker et al.21,22 Phenyl isocyanate was found to react with 40 affording two 
thiazolo[3,2-a][1,3,5]triazines 42 and 43 (Scheme 18).21 The formation of both products was suggested to 
proceed via intermediate carbodiimide 41, which depending on the reaction condition undergoes either 
[4+2] cycloaddition with another molecule of phenyl isocyanate providing 42 or dimerization to 43. 
Using excess of phenyl isocyanate and mild reaction conditions allowed preparation of 42 in good yield, 
whereas prolonged heating equimolar quantities of 40 and phenyl isocyanate resulted in the isolation of 



























i: PhNCO (3.5 eq.), benzene, rt, 3-4 h - 42 (94%) 
   PhNCO (1.5 eq.), benzene, rt, 30-40 h - 42 (20%), 43 (50%)





The reaction of 40 with diphenylcarbodiimide provided 44 (Scheme 19).22 The proposed mechanism 
involved the initial formation of intermediate 41 followed by the cycloaddition of another 
diphenylcarbodiimide molecule. The low yield of 44 was associated with the polymerization observed 

































The treatment of 2-thiazolyliminotriphenylphosphorane (40) with carbon disulfide afforded the formation 
of 47 (Scheme 20).21 It was proposed that two molecules of 40 and one molecule of carbon disulfide via 
intermediacy of 2-thiazolyl isothiocyanate (45) formed di(2-thiazolyl)carbodiimide (46), which 
underwent subsequent dimerization providing 47. Similarly, benzofused analogue 48 was also prepared, 
but with lower yield. 
 
2.1.3. Synthesis of thiazolo[3,2-a][1,3,5]triazines using other multicomponent reactions of 
2-aminothiazoles and their derivatives. 
The pseudo-four-component reaction of 2-aminothiazole (49) with phosgene afforded 
3-(2-thiazolyl)thiazolo[3,2-a][1,3,5]triazin-2,4-dione (51) (Scheme 21).23 The mechanism of the reaction 
 
was based on the dimerization of in situ formed 2-thiazolyl isocyanate (50). Analogous benzofused dimer 
















































1) COCl2, -10 
oC





















When 2-aminobenzothiazoles (36) were heated with excess of dimethylcyanamide, fused triazines 52 
were formed instead of expected guanidines (Scheme 22).24 Two molecules of 36 and two molecules of 





2 Me2NCN, reflux, 1 hN
S NH2
N














Benzothiazoazacyanines (bis-benzothiazolo[3,2-a:3’,2’-d][1,3,5]triazin-12-ium iodides) 53 were 
conveniently prepared from 2-aminobenzothiazoles (36) by the reaction with diiodomethane at high 
temperature (Scheme 23).25,26 Recently, the binding of 53 to a variety of nucleic acid sequences was 
investigated. With poor affinity to the duplex DNA strands, compounds 53 exhibited tight binding to 






















13-(4-Methoxyphenyl)-13H-bis-benzothiazolo[3,2-a:3’,2’-d][1,3,5]triazin-12-ium bromides (55), 
structurally related to 53, were synthesized by treatment of 2-aminobenzothiazoles (36) with 54 (Scheme 
24).29 When equimolar mixture of 36 with R = Me and R = MeO was used in the reaction, the product 
with unsymmetrical substitution was isolated in the yield of 22% together with about 10% of each 




















The three-component solvent-free reaction of 2-amino-4-arylthiazoles (56) with aromatic aldehydes and 
ammonium thiocyanate was reported30 to afford thiazolo[3,2-a][1,3,5]triazines 57 (Scheme 25). Using 
microwave irradiation substantially improved yields of 57 and shortened the reaction time. The products 
(57) were further effectively glycosylated at N-3.  
Another three-component solvent-free synthesis of thiazolo[3,2-a][1,3,5]triazines 59 was performed using 
thiazole Schiff bases 58, ammonium acetate and aromatic aldehydes (Scheme 26).31 This methodology 
was also extended to C-nucleosides 59 by application of aldoses instead of benzaldehydes.32 In all cases, 
 
microwave irradiation was more efficient than conventional heating due to shorter reaction time and 
higher yields of 59. Moreover, under the microwave irradiation conditions, the reaction 









R2CHO, NH4SCN,  or MW
R1 = Ph, 4-MeC6H4; R


















3CHO,  or MW
R1 = Ph, 4-MeC6H4; R
2 = Ph, 4-MeOC6H4, 4-ClC6H4; 








2.1.4. Synthesis of thiazolo[3,2-a][1,3,5]triazines via reactions of 2-aminothiazoles with C-N-C 
triatomic synthons.  
The large number of readily available 2-aminothiazoles makes them popular as building blocks for the 
construction of thiazolo[3,2-a][1,3,5]triazines. A variety of the -C-N-C- triatomic synthons were applied 
to build properly substituted 1,3,5-triazine ring on the 2-aminothiazole scaffold. However, regiochemistry 
of the ring closure was not always discussed and the structure assignments were often uncertain.  
The isocyanates and their analogues, bearing at the nitrogen atom another reactive electrophilic group, 
represent one type of the commonly used -C-N-C- triatomic synthons. The nature of the electrophilic 
group attached to the isocyanate determines the substitution on the triazine ring as well as affects the 
regioselectivity of the reaction.  
Two alternative pathways are possible for the reactions of isocyanates with 2-aminothiazoles depending 
on the site of electrophilic attack of the isocyanate group. The reaction of 2-aminothiazole (49) with 
isocyanates 60 in the presence of base might theoretically proceed via addition of isocyanate group to 
exo- or endocyclic nitrogen atom thus resulting in the formation of two regioisomeric products 61 and 62, 
respectively (Scheme 27). Initially, this reaction was reported33,34 to afford 
3,4-dihydrothiazolo[3,2-a][1,3,5]triazin-2-ones (61), but no evidence were provided in support of the 
 
product identity. Later, structure 62 was assigned for the products of similar reactions on the basis of the 
chemical shift of the CF3 signal in the 
19F NMR spectra.35 These data also seem to be insufficient for 























Et2O, TEA, rt, 2 h
benzene, TEA, rt, 3 h
R1= Ph, R2 = CHCl2, 71% (61a); CCl3, 70% (61b)
R1= Ph, R2 = CF3, 72% (62a); t-Bu, 64% (62b); R
1 = 4-MeC6H4, R
2 = CF3, 59% (62c)  
Scheme 27 
The product of the reaction of 2-aminothiazole (49) with l-hydroxy-2,2,2-trichloroethyl isocyanate (63) 
was reported36 as similar to 61 4-trichloromethyl-3,4-dihydrothiazolo[3,2-a][1,3,5]triazin-2-one (64) 
(Scheme 28). The regioisomeric structure was not discussed. The hydroxyl of 63 acted as a leaving group 












49 63 64  
Scheme 28 
The benzofused analogue of 64 – tricyclic structure 66 was obtained from 2-aminobenzothiazole (36) and 










THF, 20 oC, 15 min
CCl3 CCl3
80%
36 65 66  
Scheme 29 
 
Two isomeric structures 2-methoxythiazolo[3,2-a][1,3,5]triazin-4-one (68) and 2-methoxy- 
thiazolo[3,2-a][1,3,5]triazin-4-one (69) were proposed for the product of the reaction of 2-aminothiazole 
























49 67 68 69  
Scheme 30 
The chemical shift of the CF3 signal in the 
19F NMR spectra was used as an evidence supporting 
formation of thiazolo[3,2-a][1,3,5]triazin-4-ones 71 in similar reaction of 49 with 1,1-dichloro substituted 














benzene, TEA, rt, 3 h
O
R




The reaction of 2-aminothiazole (49) with phenoxycarbonyl isocyanate (72) was reported39,40 to produce 
thiazolo[3,2-a][1,3,5]triazin-2,4-dione (73), which was used for the preparation of potent 5-HT2-receptor 






























DEAD, PPh3, DMF, rt, 30 min
pA2 (5-HT2) = 7.9  
Scheme 32 
2-Aminothiazoles with alkylated amino group (75) reacted with 72 affording mesoionic 
























Gotthardt and Blum43 reported the synthesis of benzofused mesoionic 
thiazolo[3,2-a][1,3,5]triazin-2,4-dione 78 by treatment of amine 77 with phenoxycarbonyl isocyanate (72) 























Two alternative pathways were reported for the reactions of N-benzoyl isothiocyanate (79, R = Ph) with 
2-aminothiazoline (18) (Scheme 35). Klayman and Woods44 obtained 80 and confirmed the 
regiochemistry of the reaction by spectral data and chemical properties of the product. Together with 80 
(10%), two other products i.e. N-benzoyl-N’-(2-thiazolin-2-yl)thiourea (28%) and thiocyanate of 
2-benzamido-2-thiazoline (14%) were isolated from the reaction. Later, another structure 81 was assigned 
for the product of the reaction of 18 with N-aroyl isothiocyanates (79) formed in situ from the 
corresponding acid chloride and ammonium thiocyanate.45 The regioisomeric structures 80 were not 





















MeCN, rt, 10 h
acetone, reflux, 2 h
R= Ph, 85% (81a); 2-ClC6H4, 75% (81b); 4-ClC6H4, 77% (81c); 





Barnikow and Bödeker 46 explored the reaction of 2-aminothiazole (49) with N-benzoyl isothiocyanate 
(79) (Scheme 36). They reported formation of 2-phenylthiazolo[3,2-a][1,3,5]triazin-4-thione (82b) as a 
main product (22%) together with N-benzoyl-N’-(2-thiazolyl)thiourea (19%) and 2-benzoylaminothiazole 
(0.5%). The report47 on the isolation of regioisomeric 4-phenylthiazolo[3,2-a][1,3,5]triazin-2-thione (83) 
seems to be erroneous as the X-ray crystallography data48 for the similarly obtained product supported the 
structure of 2-phenylthiazolo[3,2-a][1,3,5]triazin-4-thione (82b). Analogously, 2-propyl substituted 
compound 82a was prepared and its molecular and crystal structure were described.49 A series of 2-aryl 
substituted thiazolo[3,2-a][1,3,5]triazin-4-thiones (82) was synthesized by Saeed et al.50 with surprisingly 




















R = Pr (82a); Ph, 22% (82b); 4-MeC6H4, 90% (82c); 4-NO2C6H4, 93% (82d); 2-thienyl, 93% (82e)
49 79 82 83
 
Scheme 36 
N-Aryl benzimidoyl isothiocyanates 84 were reported to react with 2-aminothiazole (49) similarly to 79 
providing 2-arylthiazolo[3,2-a][1,3,5]triazin-4-thiones (82) (Scheme 37).51 The addition of 84 to anilines, 
formed in the reaction after nucleophilic substitution of the imidoyl group, resulted in the formation of 














R1 = Ph, R2 = Ph, 47% (82b) and 42% (85a);
R1 = 4-NO2C6H4, R















Analogously, 2-phenylthiazolo[3,2-a][1,3,5]triazin-4-thione (82b) was prepared by treatment of 



















8649 82b  
Scheme 38 
 
2-Aminothiazoline (18) was quantitatively converted to 88 via the reaction with ethoxycarbonyl 
isothiocyanate (87) (Scheme 39). Initially, the regioisomeric structure 89 was assigned to the product,53 
but the detail structure investigations by Klayman and Woods54 and crystallographic information55 proved 
that isothiocyanate group of 87 attacked endocyclic nitrogen atom of 2-aminothiazoline (18), affording 88 




















18 87 88 89  
Scheme 39 
The steric effect of the gem-dimethyl substitution at carbon atom adjacent to the endocyclic nitrogen of 
thiazoline ring was explored.54 The treatment of 2-amino-4,4-dimethylthiazoline (90) with 87 afforded the 
formation of 4-thioxothiazolo[3,2-a][1,3,5]triazin-2-one 91 as a sole regioisomer (Scheme 40). However, 


















90 87 91  
Scheme 40 
The reaction of 2-aminothiazoles (92) with ethoxycarbonyl isothiocyanate (84) was studied in details by 
Nagano et al.56-58 The effects of substitutions in the thiazole ring on the product yields and composition 
were explored.56 The formation of 4-thioxothiazolo[3,2-a][1,3,5]triazin-2-ones 93 was observed when 
5-substituted 2-aminothiazoles (92) with pKa above 5 were treated with 87 (Scheme 41). However, the 
reaction lacked regioselectivity and was only fairly chemoselective. Together with 93, three other 
products, namely N-ethoxycarbonyl-N’-(2-thiazolyl)thioureas (94), N-(2-thiazolyl)urethanes (95) and 
N-(ethoxythiocarbonyl)urethane (96) were isolated from the reaction mixtures. In case of 
2-aminothiazoles with the pKa below 5, no thiazolo[3,2-a][1,3,5]triazines were isolated from the reaction. 
Regardless the pKa value, 4-substituted 2-aminothiazoles in the reaction with 87 also did not afford 
thiazolo[3,2-a][1,3,5]triazines. Changing the ethoxy group in 87 to the methoxy one improved yield of 
93a (R = H) from 29% to 41%.57 The higher alkoxy group (n-PrO, i-PrO, n-BuO and i-BuO) decreased 
yields of 93a to 19-26%. It was found that on heating, 94a (R = H) can undergo cyclization to 
2-thioxo-thiazolo[3,2-a][1,3,5]triazin-4-one (98) (vide infra Scheme 83).57 Compounds 93 were claimed 










































Two regioisomeric thiazolo[3,2-a][1,3,5]triazines 93a and 98 were isolated from the reaction of 
2-aminothiazole (49) with phenoxycarbonyl isothiocyanate (97) (Scheme 42).57 The formation of another 

































2-Aminothiazoles with alkylated amino group (75) were shown to behave differently in the analogous 
reactions. The formation of regioisomeric mesoionic thiazolo[3,2-a][1,3,5]triazines 100 and 101 was 
observed when 75 reacted with ethoxycarbonyl isothiocyanate (87) and phenoxycarbonyl isothiocyanate 
(97), respectively (Scheme 43).42 The structures 100 and 101 were assigned on the basis of their further 
chemical transformations.  
2-Arylaminothiazolo[3,2-a][1,3,5]triazin-4-thiones (103) were synthesized from 2-aminothiazole (49) and 
formamidinoyl isothiocyanates 102 (Scheme 44).59 The products of the addition of 102 to the amino 
group of 49, guanylthioureas 104 were also isolated from the reaction. Using analogues of 102 with 
piperidino or diethylamino substituents instead of morpholino moiety was reported to give the same 
products (103) of the triazine ring annelation.  
It was reported,60 that N-(1-hydroxyimino-2-oxopropyl)pyridinium chloride (105) can be used as a stable 
and convenient substitute for acetyl isocyanate. The dehydrochlorination of salt 105 provided 106, which 
subsequently rearranged to the active complex of pyridine with acetyl isocyanate (107) (Scheme 45). The 
traces of 2-methylthiazolo[3,2-a][1,3,5]triazin-4-one (108) were detected in the reaction of 105 with 
 
2-aminothiazole (49) in chloroform. Using 49 absorbed on SiO2 (1:2) allowed isolation of 108 with the 
11% yield. Changing the 2-aminothiazole (49) – SiO2 ratio to 1:4 improved yield of 
2-methylthiazolo[3,2-a][1,3,5]triazin-4-one (108) to 22%. Additionally, N-acetyl-N’-(2-thiazolyl)thiourea 














R = Et, 47% (100a);














PhO R = Et, 70% (101a);
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Vovk and Dorokhov61 found that reaction of 2-aminothiazole (49) with carbodiimide 110, structurally 
related to isocyanates 60, in mild conditions afforded thiazolo[3,2-a][1,3,5]triazine 111 with 

























Thiazolo[3,2-a][1,3,5]triazin-4-ones 113 (analogues of 62), substituted with two geminal trifluoromethyl 
groups, were prepared by treatment of 2-aminothiazoles (92) with hexafluoroacetone 
ethoxycarbonylimine (112) in DMF under TsOH catalysis (Scheme 47).62 The reaction of 











DMF, TsOH, reflux, 1 hN
S NH2
O
R = H, 61% (113a); Me, 70% (113b); 










92 112 113 114
Scheme 47 
Similarly, benzofused analogues 116 were prepared from 2-aminobenzothiazoles 115 and imine 112 











DMF, TsOH, reflux, 1 hN
S NH2
O
R = Cl, 78% (116a); OEt, 71% (116b); 














Acylimines of hexafluoroacetone (118) were reported63 to react with 2-aminothiazoline (18) with 
formation of 4-substituted 2,2-bis(trifluoromethyl)-6,7-dihydrothiazolo[3,2-a][1,3,5]triazines (119) 











DMF, TEA, 90-100 oC, 2 hN
S NH2
R










R1 = H, R2 = Me, 78% (120a); 






Diphenyl iminodicarboxylate (121) was found to be a convenient alternative for relatively unstable 
phenoxycarbonyl isocyanate (72) (vide supra Scheme 32). The reaction of 2-aminothiazoline (18) with 
121 in mild conditions resulted in the formation of 6,7-dihydrothiazolo[3,2-a][1,3,5]triazin-2,4-dione 
(122) with good yield (Scheme 50).64 The reaction of 2-aminothiazole (49) with 121 required heating in 



















18 121 73122  
Scheme 50 
Heating 2-aminothiazoline (18) with N-ethoxycarbonyl thiobenzamides (123) in ethanol was reported65 to 
afford 2-aryl-6,7-dihydrothiazolo[3,2-a][1,3,5]triazin-4-ones (124) (Scheme 51). The conversion of 124a 









EtOH, reflux, 5-16 hN
S NH2
O






Using carbamoyl chloride 126 was claimed66 to be effective for the 1,3,5-triazine ring annelation on 
2-amino-4-methylthiazole (125) (Scheme 52). However, the question on the structure of products (127 or 
128) remained open. Similarly, when 2-aminobenzothiazole (36) was reacted with 126 (R = Ph) on 



















i: Et2O, 30 min - R = Cl (127a/128a); 

















4-Dimethylamino-2-phenylthiazolo[3,2-a][1,3,5]triazinium perchlorate (132) was obtained by heating of 

















49 131 132  
Scheme 53 
The reaction of 2-aminothiazole (49) with cyclic iminium salt 133 was reported68 to afford 
thiazolo[3,2-a][1,3,5]triazinium iodide 134 (Scheme 54). When 4-substituted 2-aminothiazoles were used 
in the reaction, the triazine ring was not formed and only nucleophilic addition or substitution at the 


















49 133 134  
Scheme 54 
 
2-Amino-4-phenylimino-1,3,5-triazino[2,1-b]benzothiazole (136a) was prepared via reaction of 
2-aminobenzothiazole (36) with sodium salt of N-cyano-N’-phenyl thiourea (135) (Scheme 55).69 A 
number of substituted analogues of 136, claimed to possess immuno-regulant activity, were synthesized 
by this manner or using N-cyano-N’-phenyl-S-methyl isothiourea instead of 135. However, low yields of 















36 135 136a  
Scheme 55 
Heating 2-aminobenzothiazole (36) with N-(chloromethyl)benzimidoyl chloride (137) was reported70 to 
afford 2-phenyl-4H-1,3,5-triazino[2,1-b]benzothiazole (138) (Scheme 56). The assignment of structure 









135 oC, 0.5 h
23%Cl Ph Ph
36 137 138  
Scheme 56 
The reaction of 2-aminobenzothiazole (36) with N,N-bis(chloromethyl)acetamide (139) proceeded via 
double alkylation of endo- and exocyclic nitrogen atoms of 36, thus resulting in the formation of 
















2.1.5. Synthesis of thiazolo[3,2-a][1,3,5]triazines via formal [4+2] cycloaddition.  
Commonly, this strategy was realized in the reactions of hetero-1,3-dienes - aminothiazole derivatives as 
4-component with isocyanates and their analogues (2-dienophiles). Thus, formamidine 21 upon 
treatment with aryl isocyanates in the mild conditions underwent [4+2] cycloaddition with the formation 
of 141 (Scheme 58).16 The reaction was found to be exothermic and very sensitive to the conditions. 
Changing ratio of the reagents and temperature substantially affected the reaction pathway and 












R = Ph, 91% (141a); 4-MeC6H4, 77% (141b)




The cycloaddition of phenyl isothiocyanate to Schiff bases 58 was reported72,73 to afford 











PhPhNCS, toluene, reflux, 4-6 h
R1 = 4-PhC6H4; R
2 = Ph, 57% (142a), 4-(Me2N)C6H4, 49% (142b), 4-NO2C6H4, 55% (142c)




Heating 2-(arylmethyleneamino)benzothiazoles (29) with phenyl isocyanate or phenyl isothiocyanate in 
toluene allowed the preparation of 143 (Scheme 60).74 The reaction pathway was found17 to strongly 










PhPhNCX, toluene, reflux, 15-24 h
X = O; R = 4-ClC6H4, 60% (143a), 4-NO2C6H4, 55% (143b)















R3R3NCS, toluene, reflux, 4-6 h
R1 = H, Me; R2 = 2-ClC6H4, 2-MeC6H4, 4-MeC6H4; R








The reaction of 2-(benzylidenamino)benzothiazoles (146) with ammonium thiocyanate resulted in the 
annulation of the triazine ring affording 147 (Scheme 62).76,77 Using microwave irradiation was reported77 











NH4SCN, dioxane, reflux, 4-6 h or MW 1-2 min






It was reported78 that 2-(4-methyl)thiazolyl isothiocyanate (148) reacted with Schiff bases and aryl 
isocyanates providing thiazolo[3,2-a][1,3,5]triazin-2-thiones 149 and 150, respectively (Scheme 63). 
Despite strong tendency to dimerization of 148, dimer 151 (a side product in the synthesis of 148) was 
not isolated from the reactions. Interestingly, no reaction was observed when 2-(4-phenyl)thiazolyl 








Me R1 = Ph, R2 = Me, 66% (149a); 
R1 = Ph, R2 = Et, 66% (149b); 
R1 = 4-(Me2N)C6H4, R
2 = Me, 72% (149c); 
R1 = 4-MeOC6H4, R













R = Ph, 87% (150a);
      3-ClC6H4, 61% (150b); 
      4-BrC6H4, 54% (150c); 
      1-Naphth, 65% (150d)


















The cyclodimerization of isocyanate 153, derived from hydrazide 152, resulted in the formation of 

















1) Na2NO3, HCl, AcOH, CHCl3, 
    benzene, 0-5 oC, 30 min;









It was found that 3-phenylthiazolo[3,2-a][1,3,5]triazin-2,4-dione (26a) on heating lost phenyl isocyanate 
and form 51 as a product of the cyclodimerization of 2-thiazolyl isocyanate (50) (Scheme 65).23 
























26a 51 31a  
Scheme 65 
An example of the cyclodimerization of Schiff base 29b was reported by Abdel-Rahman.74 On prolonged 


















2.1.6. Synthesis of thiazolo[3,2-a][1,3,5]triazines via 1,3,5-triazine ring annelation on 2-substituted 
thiazoles using one-carbon inserting reagents.  
George and Tahilramani80 reported synthesis of 2-phenylthiazolo[3,2-a][1,3,5]triazin-4-one (157) via 
inserting the carbonyl group by treatment of N-(thiazol-2-yl)benzamidine (156) with phosgene (Scheme 
67). From the reaction of 156 with thiophosgene, 157 was isolated instead of the thiocarbonylation 












X=CCl2, toluene, reflux, 6 h
X = O, 49%; S, 32%
156 157  
Scheme 67 
Similarly, benzofused analogue 130 was synthesized from N-(benzothiazol-2-yl)benzamidine (158) and 











O=CCl2, toluene, reflux, 6 h
42%
158 130  
Scheme 68 
3-Cyclohexylthiazolo[3,2-a][1,3,5]triazin-2,4-dione (160) was prepared from urea 159 by treatment with 











O=CCl2, TEA, AcOEt, rt, 24 h
159 160  
Scheme 69 
Similarly, thiazolidine substituted ureas 161 were converted to 162 by the treatment with phosgene or 













R3O=CCl2  or  ClCO2CCl3
161 162  
Scheme 70 
Tetracyclic system 164 comprising thiazolo[3,2-a][1,3,5]triazin-4-one and benzimidazole was also 
prepared from 2-(thiazol-2-yl)benzimidazole (163) using phosgene as a one-carbon inserting reagent 
(Scheme 71).84  
A variety of electrophilic reagents were adopted as one-carbon inserting reagents for the 1,3,5-triazine 
ring formation on the scaffold of thiazolyl and benzothiazolyl substituted guanidines. The reaction of 
2-thiazolyl guanidines 165 with ethyl chloroacetate in the presence of sodium methylate was reported85 to 
 
afford thiazolo[3,2-a][1,3,5]triazine 166 (Scheme 72). In similar conditions, diethyl oxalate with 165 














































NaOMe, MeOH, rt, 2 h
40%
R = H, 40% (167a), 20% (168a);




167 168  
Scheme 72 
The analogous reaction of 2-benzothiazolylguanidine (169a) in with ethyl chloroacetate was applied for 
the synthesis of tricyclic 170 (Scheme 73).85 The triazine ring closure of 169a with diethyl oxalate 
































Kreutzberger86 reported the synthesis of 1,3,5-triazino[2,1-b]benzothiazol-2-imine (173) from 
2-benzothiazolyl guanidine (169a) and ethyl formate (Scheme 74). The yield of 173 was improved by the 













HCO2Et, MeOH, reflux, 16 h
or
24.5% or 80%
,  piperidine, EtOH, reflux, 6 h
1/3
169a 173  
Scheme 74 
The triazine ring closure with introduction of carbonyl group was achieved by treatment of 
2-benzothiazolyl guanidines (169) with diethyl azodicarboxylate87 or phenyl and tosyl isocyanates88,89 















i: DEAD, dioxane, reflux, 12 h
R = H, 26% (174a);
i: PhNCO, DME, MW, 180 oC, 15 min
R = H, 96% (174a); Cl, 90% (174b); CF3, 95% (174c
i: TsNCO, dioxane, reflux, 4 h
R = H, 63% (174a);
 
Scheme 75 
Depending on the conditions applied, two types of the heterocyclization products were isolated from the 
reaction of 169 with phenyl isothiocyanate (Scheme 76). Heating 169 with phenyl isothiocyanate in 
pyridine afforded ring closure thiocarbonylation product 175.88 Under microwave irradiation, 

















PhNCS, Py, reflux, 4 h
65%
PhNCS, DME, MW, 180 oC, 15 min







The synthesis of 136a was also carried out via the cyclization of 2-benzothiazolyl guanidine (169) with 











Ph-N=CCl2, DIPEA, THF, reflux, 16 days
136a169  
Scheme 77 
1,3,5-Triazino[2,1-b]benzothiazoles 177 were prepared form guanidines 176 by subsequent treatment 


















2.1.7. Synthesis of thiazolo[3,2-a][1,3,5]triazines via intramolecular cyclization of 2-substituted 
thiazoles with the formation of 1,3,5-triazine ring. 
Etienne and Bonte90 found that in aqueous acetic acid, 2-thiazolyl substituted biuret 178 underwent 
intramolecular cyclization with methylamine elimination affording 3-methyl- 












178 179  
Scheme 79 
N-Acyl-N’-(2-thiazolyl)thioureas, prepared from 2-aminothiazoles and N-acyl isothiocyanates were used 
for the synthesis of a variety of substituted thiazolo[3,2-a][1,3,5]triazin-2-thiones. Thus, treatment 
N-cinnamoyl-N’-(2-thiazolyl)thiourea 180 with sodium ethoxide resulted in the 1,3,5-triazine ring 
annelation with the formation of 181 (Scheme 80).91  
Interestingly, structurally related thiourea 182 (R = Ph-CH=CH) with 4-(3-coumaryl) substituent on the 
thiazole ring reacted differently in the similar conditions affording cycloaddition product 183 (Scheme 
 
81).92 However, heating N-benzoyl analogue 182 (R = Ph) in n-butanol was reported92 to produce 















NaOEt, EtOH, reflux, 0.5 h
60%
180 181  
Scheme 80 
A number of thiazolo[3,2-a][1,3,5]triazin-2-thiones (185) were prepared via this type of 
cyclocondensation by heating of corresponding N-acyl-N’-(2-thiazolyl)thioureas with alkali,93 phosphoryl 
chloride94 or phosphoryl chloride / phosphorus pentachloride mixture.95,96 The biological activity 
(antiviral,95 antibacterial94 and antifungal96) of 185 was also evaluated. However, lack of an appropriate 
structural characterization and controversy of the reported experimental data significantly decrease 




























 reflux, 5 h
55%








R = PhR = Ph-CH=CH
 
Scheme 81 
Heating N-aroyl-N’-(2-benzothiazolyl)thioureas 186 in butanol resulted in the 1,3,5-triazine ring closure 
with the formation of 4-aryl-1,3,5-triazino[2,1-b]benzothiazol-2-thiones 187 (Scheme 82).97 The 
biological evaluation of 187 revealed anticonvulsant properties of the compounds in the maximum 
electroshock test in mice without signs of neurotoxicity or hepatotoxicity. 
N-Ethoxycarbonyl-N’-(2-thiazolyl)thioureas (94), which were among products of the reaction of 
2-aminothiazoles (92) with ethoxycarbonyl isothiocyanate (84) (vide supra Scheme 41), underwent 
thermal cyclocondensation affording 2-thioxothiazolo[3,2-a][1,3,5]triazin-4-ones 98 (Scheme 83).57,58 
 

















R1 = H, F, Cl, Br, Me, OMe, NO2




















O i: 180-190°C, 20 min
R1 =  R2 = H, 25% (98a);
i: 5% NaOH, rt, 12 h
R1 = H, R2 = Ph, 58% (98b);
i: NaOEt, EtOH, reflux, 0.5 h
R1 = CO2Et, R




From the reaction of N-ethoxycarbonyl-N’-(2-thiazolyl)thioureas (94) with alkylhalides in basic 
conditions, small quantities of thiazolo[3,2-a][1,3,5]triazin-4-ones 188 were isolated along with other 






























R1 = H, Me, Et, n-Bu, Ph; 
R2 = Me, Et, Pr, i-Pr, n-Bu, i-Bu, 
Bn, 
Hal = Br, I





H2C CH2CH, HC CCH;
 
Scheme 84 
In cases of alkylation of the thioureas substituted in position 4 of the thiazole ring as well as 
N-ethoxycarbonyl-N’-(5-bromothiazol-2-yl)thiourea, no formation of thiazolo[3,2-a][1,3,5]triazines was 
observed. In the presence of base or on heating, the major products of the reactions, isothioureas 190, 
were able to undergo cycocondensation affording 188 with good yields (Scheme 85).101 Other 
















i: 1N K2CO3, rt, 2 days
R1 = R2 = H, R3 = Et, 75% (188a)
i: 160-170 oC, 15 min
R1 = H, Br, Me, Et, n-Bu, Ph; R2 = H, Me, Ph;  
R3 = Me, Et, Pr, i-Pr, n-Bu, i-Bu, Bn,
                                         84-98%
190 188
i
H2C CH2CH, HC CCH,  
Scheme 85 
The reaction of N-ethoxycarbonyl-N’-(2-benzothiazolyl)thiourea with methyl iodide in basic conditions 
did not resulted in the 1,3,5-triazine ring closure. However, the major product (79%) of the reaction, 
compound 191, can be easily cyclized to 4-methylthio-1,3,5-triazino[2,1-b]benzothiazol-4-one (192) upon 











160-170 oC, 15 min
O
94%
191 192  
Scheme 86 
The heterocyclization of 193, which was isolated (46% yield) from the reaction of 2-benzothiazolyl 
guanidines (169) with diethyl azodicarboxylate in diethyl ether at room temperature, afforded 174a 














dioxane, reflux, 12 h
48%
193 174a  
Scheme 87 


















The synthesis of 2,2-bis(trifluoromethyl)-4-(4-chlorophenyl)-6,7-dihydrothiazolo[3,2-a][1,3,5]triazines 
(119c) was performed in the stepwise manner (cf. Scheme 49).63 Adduct 196, obtained with the 94% yield 
 
from the exothermic reaction between 2-aminothiazoline (18) and 4-chlorobenzoylimine of 

















196 119c  
Scheme 89 
The thermal cyclocondensation of 197, prepared with the 91% yield by treatment of 
2-aminobenzothiazole (36) with hexafluoroacetone ethoxycarbonylimine (112) in diethyl ether, afforded 
116e (Scheme 90).102 The structure of the product (116e) was confirmed by X-ray crystallography. 
Sokolov and Aksinenko62 used these data to support the regiochemistry of the direct synthesis of 116 



















The pyrimidine and 1,3,5-triazine ring closure with formation of cyclazine 199 occurred when 198 was 




















198 199  
Scheme 91 
 
2.2. Synthesis of thiazolo[3,2-a][1,3,5]triazines by annelation of the thiazole ring onto a 
1,3,5-triazine scaffold. 
Even though the annelation of the thiazole ring onto a 1,3,5-triazine scaffold was the first method for the 
synthesis of thiazolo[3,2-a][1,3,5]triazines (vide supra Scheme 1),2,3 this approach has not been 
thoroughly explored. The main contributions to this field were done by Dovlatyan et al.,104-108 who 
 
studied the reactions of 1,3,5-triazines with 1,2-dichloroethane and cyclizations of the 2-chloroethyl 
substituted 1,3,5-triazines. The reaction of triazine 200 with 1,2-dichloroethane in the presence of alkali 
was reported to result in the formation of salt 201, which was converted to the corresponding free base 





















The similar reaction of the methylated analogue of 200 provided triazine 202, which underwent further 













xylene, 115 oC, 3 h
Me NHAc Me NHAc
Cl
Cl
202 203  
Scheme 93  
The cyclocondensation of 2-(2-chloroethylthio)-4-dialkylamino-6-methoxy-1,3,5-triazines (204) with 
elimination of methylchloride was found to afford 205 (Scheme 94).105,106 The detail mass-spectrometry 





toluene, reflux, 5-8 h
OR1
R1 = H, R2 = NMe2, 90% (205a); NEt2, 84% (205b);












Compounds 205 were also prepared from triazines 206 via the translocative rearrangement to 207 and 
subsequent intramolecular cyclization with the methylchloride elimination (Scheme 95).108 The 
conversion of 206 into 2-dialkylamino-6,7-dihydrothiazolo[3,2-a][1,3,5]triazin-4-ones (205) was also 
performed by heating at 180-190 °C without isolation of 207.  
The similar synthesis of 2-dialkylamino-6,7-dihydrothiazolo[3,2-a][1,3,5]triazin-4-thiones (210) from 
corresponding 208 was proposed105 to involve transfer of the chloroethyl group to the endocyclic nitrogen 
(Scheme 96). This pathway was suggested by intermediates 209, which were isolated when the reaction 






180-190 oC, 3 h
O
R- MeCl








































The treatment of triazines 211 with bromoacetophenones (212, R1 = H) in acetone resulted in the 
formation of salts 213 (Scheme 97), which were claimed109 as potential antiulcer agents. The similar 
reaction of 211 with 3-aroyl-3-bromopropionic acids (212, R1 = CH2CO2H) in methanol at ambient 
temperature afforded corresponding adducts 213, which were able to increase survival time of the mice 



















R1 = H, CH2CO2H;
R2 = Me, Et, CH2=CHCH2, Bn, 3-MeOC6H4CH2; 
R3 = H, Me, CH2=CHCH2, Bn
R1
R1













The cyclocondensation of 215 in polyphosphoric acid was reported111 to produce 216 (Scheme 98). 
2,4,6-Triphenyl-3,4-dihydro-2H-thiazolo[3,2-a][1,3,5]triazine (216a, R1 = H, R2 = R3 = Ph) was explored 













R1 =  H, Ac; R2 = Me, Ph, 4-MeC6H4; R











Acids 217 were found to undergo intramolecular cyclization affording 218 (Scheme 99).113,114 
2,4-Diphenyl-2,3,4,7-tetrahydrothiazolo[3,2-a][1,3,5]triazin-6-one (218a, R1 = H, R2 = Ph) was explored 























2.3. Synthesis of thiazolo[3,2-a][1,3,5]triazines via formation of the thiazole and 1,3,5-triazine ring.  
2-Amino-4-imino-1,3,5-triazino[2,1-b]benzothiazole (221) was prepared from o-aminothiophenol (219) 














EtOH, rt, 18 h, reflux, 4 h
12%
219 220 221  
Scheme 100 
3. HETEROCYCLIC SYSTEMS COMPRISING THIAZOLO[3,4-A][1,3,5]TRIAZINE CORE  
The 1,3,5-triazine ring fused with 3,4-side of thiazole has been reported only as a part of more complex 
heterocyclic systems. For example, tetracyclic compound 223 was formed by the condensation of 222 
with benzaldelyde (Scheme 101).116  
The cyclazines comprising the thiazolo[3,4-a][1,3,5]triazine and pyrimidine rings were synthesized by 
Ceder and Beijer.103,117 The reaction of 2,4-diamino-5-methylthiazole (224) with ethyl 
2-cyano-3-ethoxyacrylate followed by heating with acetic-formic anhydride resulted in the formation of 
8-ethoxycarbonyl-4-methyl-5-thia-1,3,6-triazacycl[3.2.3]azine (225) with low yield (Scheme 102).117 
 


































1) EtO-CH=C(CO2Et)CN, aq. EtOH, rt, 1 h
2) HCO2H, Ac2O, 90 
oC, 3 h
5%
224 225  
Scheme 102 
For the preparation of analogous phenyl substituted cyclazine 227, intermediate 226 was isolated and 














HCO2H, Ac2O, rt, 16 h
226 227  
Scheme 103 
The thermal cyclocondensation of 228, a product of the acetylation of amine 226, allowed the synthesis of 


















228 229  
Scheme 104 
4. CONCLUSION 
A variety of effective methods for the preparation of thiazolo[3,2-a][1,3,5]triazines has been developed, 
mainly by the annelation of the 1,3,5-triazine ring onto a 1,2,4-triazole scaffold. The spectrum of known 
biological activities of compounds bearing thiazolo[3,2-a][1,3,5]triazine skeleton includes antitumor, 
 
antiviral, antibacterial, antifungal, anthelmintic, and anticonvulsant activities. The examples of the 
phospholipase C- inhibitors, 5-HT2-receptor antagonists, and selective DNA binding agents have been 
reported. However, these data are sporadic and more systematic medicinal chemistry investigations of 
thiazolo[3,2-a][1,3,5]triazines are required. The present review aims to serve as a background for the 
research in this area.  
The chemistry of thiazolo[3,4-a][1,3,5]triazines remains in the initial development stages and its potential 
is to be discovered in future.  
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